FAM50B is a eutherian-specific imprinted gene that arose by retrotransposition from the X-linked XAP-5/FAM50A gene before the radiation of placental mammals, retaining an intronless open reading frame and showing testis-enriched expression consistent with a role compensating for X-linked silencing during spermatogenesis (PMID:10534398). Its expression is controlled by a maternally methylated differentially methylated region at its promoter CpG island, driving paternal-allele-specific expression in a manner unique to the human/eutherian lineage, with biallelic expression in mouse and opossum where differential methylation is absent (PMID:21421564, PMID:21593219, PMID:21749726); this allele-specific methylation is detectable in somatic tissue including blood (PMID:24130816), and the locus also produces a paternally expressed antisense transcript (PMID:21421564). Functionally, FAM50B is redundant with its paralog FAM50A: combinatorial CRISPR disruption of both genes causes loss of cellular fitness, micronucleus formation, and broad transcriptional perturbation, and because FAM50B is silenced across multiple tumour types, those cancers become dependent on FAM50A, defining a synthetic-lethal vulnerability (PMID:33637726, PMID:35417719). Beyond this paralog relationship and its imprinting biology, the biochemical activity of the FAM50B protein itself has not been characterized in the available corpus.